Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2008-01-05 (18 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logicielsLocation: LATTES (34970), Herault
AURORA MEDICAL SYSTEMS : revenue, balance sheet and financial ratios
AURORA MEDICAL SYSTEMS is a French company
founded 18 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels.
Based in LATTES (34970),
this company of category PME
shows in 2021 a revenue of 292 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - AURORA MEDICAL SYSTEMS (SIREN 502051063)
Indicator
2021
2020
2019
2018
2017
2016
Revenue
291 641 €
552 922 €
606 479 €
479 048 €
439 939 €
383 626 €
Net income
10 111 €
814 €
8 591 €
17 285 €
14 965 €
8 800 €
EBITDA
12 599 €
1 381 €
11 606 €
21 492 €
18 856 €
10 941 €
Net margin
3.5%
0.1%
1.4%
3.6%
3.4%
2.3%
Revenue and income statement
In 2021, AURORA MEDICAL SYSTEMS achieves revenue of 292 k€. Revenue is declining over the period 2016-2021 (CAGR: -5.3%). Significant drop of -47% vs 2020. After deducting consumption (196 k€), gross margin stands at 95 k€, i.e. a rate of 33%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 13 k€, representing 4.3% of revenue. Positive scissor effect: EBITDA margin improves by +4.1 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 10 k€, i.e. 3.5% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2021)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
291 641 €
Gross margin (2021)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
95 445 €
EBITDA (2021)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
12 599 €
EBIT (2021)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
12 216 €
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
10 111 €
EBITDA margin (2021)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
4.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.3 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 3.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
20.334%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.442%
Cash flow / Revenue (2021)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
3.598%
Repayment capacity (2021)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
5.306
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution AURORA MEDICAL SYSTEMS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
Debt ratio
0.534
2.712
2.658
0.343
21.027
20.334
Financial autonomy
69.124
56.391
60.653
52.849
58.369
67.442
Repayment capacity
0.13
0.403
0.37
0.092
42.103
5.306
Cash flow / Revenue
2.384%
3.63%
3.809%
1.623%
0.237%
3.598%
Sector positioning
Debt ratio
20.332021
2019
2020
2021
Q1: 0.03
Med: 16.79
Q3: 76.67
Average+25 pts over 3 years
In 2021, the debt ratio of AURORA MEDICAL SYSTEMS (20.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
67.44%2021
2019
2020
2021
Q1: 15.09%
Med: 34.83%
Q3: 54.19%
Excellent+5 pts over 3 years
In 2021, the financial autonomy of AURORA MEDICAL SYSTEMS (67.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
5.31 years2021
2019
2020
2021
Q1: 0.0 years
Med: 0.05 years
Q3: 2.06 years
Watch+24 pts over 3 years
In 2021, the repayment capacity of AURORA MEDICAL SYSTEMS (5.31) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 530.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.0x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
530.526
Interest coverage (2021)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.968
Liquidity indicators evolution AURORA MEDICAL SYSTEMS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
Liquidity ratio
327.631
236.484
264.305
212.484
340.271
530.526
Interest coverage
0.0
0.0
0.0
0.0
0.0
0.968
Sector positioning
Liquidity ratio
530.532021
2019
2020
2021
Q1: 146.89
Med: 216.41
Q3: 347.88
Excellent+20 pts over 3 years
In 2021, the liquidity ratio of AURORA MEDICAL SYSTEMS (530.53) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.97x2021
2019
2020
2021
Q1: 0.0x
Med: 0.09x
Q3: 2.29x
Good+35 pts over 3 years
In 2021, the interest coverage of AURORA MEDICAL SYSTEMS (1.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 54 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 93 days. Excellent situation: suppliers finance 39 days of the operating cycle (retail model). Inventory turnover is 39 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 87 days of revenue, i.e. 70 k€ to permanently finance. Notable WCR improvement over the period (-48%), freeing up cash.
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
70 341 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
54 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
93 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
39 j
WCR in days of revenue (2021)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
87 j
WCR and payment terms evolution AURORA MEDICAL SYSTEMS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
Operating WCR
135 846 €
25 741 €
124 145 €
83 166 €
20 867 €
70 341 €
Inventory turnover (days)
18
4
7
3
12
39
Customer payment term (days)
95
19
80
46
7
54
Supplier payment term (days)
97
167
110
144
84
93
Positioning of AURORA MEDICAL SYSTEMS in its sector
Comparison with sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels
Valuation estimate
Based on 61 transactions of similar company sales
(all years),
the value of AURORA MEDICAL SYSTEMS is estimated at
51 594 €
(range 13 551€ - 86 265€).
With an EBITDA of 12 599€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.33x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2021
61 tx
13k€51k€86k€
51 594 €Range: 13 551€ - 86 265€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
12 599 €×2.5x
Estimation31 492 €
6 890€ - 63 962€
Revenue Multiple30%
291 641 €×0.33x
Estimation95 803 €
27 942€ - 127 093€
Net Income Multiple20%
10 111 €×3.5x
Estimation35 540 €
8 617€ - 80 782€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 61 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels)
Compare AURORA MEDICAL SYSTEMS with other companies in the same sector:
Frequently asked questions about AURORA MEDICAL SYSTEMS
What is the revenue of AURORA MEDICAL SYSTEMS ?
The revenue of AURORA MEDICAL SYSTEMS in 2021 is 292 k€.
Is AURORA MEDICAL SYSTEMS profitable?
Yes, AURORA MEDICAL SYSTEMS generated a net profit of 10 k€ in 2021.
Where is the headquarters of AURORA MEDICAL SYSTEMS ?
The headquarters of AURORA MEDICAL SYSTEMS is located in LATTES (34970), in the department Herault.
Where to find the tax return of AURORA MEDICAL SYSTEMS ?
The tax return of AURORA MEDICAL SYSTEMS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does AURORA MEDICAL SYSTEMS operate?
AURORA MEDICAL SYSTEMS operates in the sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels (NAF code 46.51Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart